Patent · US Active

Composition of bone formation with PHSRN-RGD containing oligopeptide

US7897722B2 · kind B2 · utility

4Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2007
Grant dateMar 1, 2011
Priority date
Expiry dateNov 4, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A PHSRN-RGD-containing oligopeptide and a composition for promoting bone formation, which contains such oligopeptide as an effective ingredient. The oligopeptide promotes osteoblastic cell adhesion and differentiation and enhances bone regenerative ability, so that the inventive oligopeptide can be effectively used in regenerative treatment of bone tissue and periodontal tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.